Predicted to enable heme binding activity and heme transmembrane transporter activity. Acts upstream of or within several processes, including chordate embryonic development; embryonic digit morphogenesis; and hematopoietic or lymphoid organ development. Predicted to be located in plasma membrane. Predicted to be integral component of membrane. Predicted to be active in mitochondrion. Is expressed in ectoplacental cone; immune system; liver; placenta; and yolk sac. Used to study Diamond-Blackfan anemia. Orthologous to human FLVCR1 (FLVCR heme transporter 1). [provided by Alliance of Genome Resources, Apr 2022]